Poop transplant plus drug: a powerful combo to fight a stubborn gut infection?
NCT ID NCT03829475
Summary
This study tested if adding a drug called bezlotoxumab to a fecal microbiota transplant (FMT) works better than FMT alone to prevent C. difficile infection (CDI) from coming back. It involved 61 adults with inflammatory bowel disease (IBD) who kept getting repeat CDI. Participants were randomly assigned to receive either the FMT with the drug or the FMT with a placebo, and then followed for three months to see whose infection returned.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INFLAMMATORY BOWEL DISEASES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Brigham and Women's Hospital
Boston, Massachusetts, 02115, United States
Conditions
Explore the condition pages connected to this study.